Newsroom

Newsroom

NeoGenomics To Participate in the BofA Securities 2022 Healthcare Conference

Press Release
Read More

Travelogue 1

Blog
Read More

NeoGenomics Reports Revenue of $117 Million in the First Quarter

Press Release
Read More

NeoGenomics Inc. Announces Partnership with Lilly for Lung Cancer Sponsored Testing Program Utilizing the NeoTYPE(R) DNA and RNA Assay

Press Release
Read More

Talking Cancer: Conversation with Ultramarathoner, Triathlete, Mother, Wife, Business Owner and Overachiever, Isabella de la Houssaye

Blog
Read More

Actionable fusions detected by RNA-seq co-occur with PD-L1 expression and driver mutations in solid tumors patients

Literature
Read More

Comprehensive characterization of the biology of inflammatory bowel disease-associated colorectal cancer using the GeoMx® Digital Spatial Profiler (DSP)

Literature
Read More

Custom PhenoImager™ fluorescent multiplex IHC panel identifies mature tertiary lymphoid structures in colorectal cancer

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients